Special Issue about Head and Neck Cancers: HPV Positive Cancers

Special Issue about Head and Neck Cancers: HPV Positive Cancers

The oropharynx has become the leading primary site for Human Papilloma Virus (HPV)-associated head and neck cancer. HPV positive oropharyngeal squamous cell carcinoma (HPV+ OSCC) has emerged as an epidemic not easily recognized by many physicians, resulting in delays in diagnosis and management. HPV...

Full description

Bibliographic Details
Main Authors:	Panagiota Economopoulou, Ioannis Kotsantis, Amanda Psyrri
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	International Journal of Molecular Sciences
Subjects:	head and neck cancer HPV oropharyngeal cancer de-escalation
Online Access:	https://www.mdpi.com/1422-0067/21/9/3388

Similar Items

De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
by: Panagiota Economopoulou, et al.
Published: (2021-09-01)

De-escalation of radiotherapy for the treatment of HPV-associated head and neck cancer: A case report and a word of caution
by: Andrew Keller, et al.
Published: (2017-01-01)

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond
by: Alexander Rühle, et al.
Published: (2021-05-01)

Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
by: Panagiota Economopoulou, et al.
Published: (2020-11-01)

Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
by: Panagiota Economopoulou, et al.
Published: (2019-08-01)

PAPILLOMAVIRUSES: HPV AS THE ETIOLOGICAL FACTOR OF HEAD AND NECK CANCERS
by: Michał Wiciński, Kamil Leis, et al.
Published: (2018-06-01)

Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer
by: Amelio, A.L, et al.
Published: (2022)

A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide
by: Amanda F. Carlander, et al.
Published: (2021-07-01)

Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience
by: Titaporn Nopmaneepaisarn, et al.
Published: (2019-11-01)

Toxicity Reduction in the Treatment of HPV Positive Oropharyngeal Cancer: Emerging Combined Modality Approaches
by: Sarah Deschuymer, et al.
Published: (2018-10-01)

The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
by: Miren Taberna, et al.
Published: (2018-12-01)

HPV-related HNC – new challenge and hope for head and neck cancer subjects
by: Krzysztof Szyfter, et al.
Published: (2018-06-01)

Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC)
by: Kedar Kirtane, et al.
Published: (2018-12-01)

The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
by: Marieke Bamps, et al.
Published: (2021-07-01)

HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
by: Jason K. Wasserman, et al.
Published: (2017-01-01)

Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer
by: Sonia N. Whang, et al.
Published: (2015-09-01)

Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status
by: Adam Brewczyński, et al.
Published: (2021-12-01)

Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study
by: Marta Tagliabue, et al.
Published: (2020-11-01)

The significance of human papillomaviruses in head and neck cancer development
by: Božić Ljiljana, et al.
Published: (2016-01-01)

The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes
by: Jane Harrowfield, et al.
Published: (2021-02-01)

HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies
by: Rüveyda Dok, et al.
Published: (2016-03-01)

Molecular biology of head and neck cancers
by: Deepa Philip, et al.
Published: (2016-01-01)

The Role of Human Papilloma Virus in Dictating Outcomes in Head and Neck Squamous Cell Carcinoma
by: Shane Brennan, et al.
Published: (2021-06-01)

Molecular and Functional Profiles of Exosomes From HPV(+) and HPV(−) Head and Neck Cancer Cell Lines
by: Sonja Ludwig, et al.
Published: (2018-10-01)

A Current Update on Human Papillomavirus-Associated Head and Neck Cancers
by: Ebenezer Tumban
Published: (2019-10-01)

Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
by: Haitham Mirghani, et al.
Published: (2018-01-01)

HPV Status as Prognostic Biomarker in Head and Neck Cancer—Which Method Fits the Best for Outcome Prediction?
by: Jan Philipp Kühn, et al.
Published: (2021-09-01)

Dual role for p16 in the metastasis process of HPV positive head and neck cancers
by: Rüveyda Dok, et al.
Published: (2017-06-01)

Effect of Oral Zinc Sulphate in Preventionof Radiation Induced OropharyngealMucositis During and After Radiotherapyin Patients with Head and Neck Cancers
by: Mohammad Mohammadianpanah, et al.
Published: (2010-04-01)

HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas
by: Jérôme R. Lechien, et al.
Published: (2020-04-01)

Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations
by: Stefan Holzhauser, et al.
Published: (2021-05-01)

APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma
by: Daniel L. Faden, et al.
Published: (2021-08-01)

The translational significance of epithelial‐mesenchymal transition in head and neck cancer
by: Christian A Graves, et al.
Published: (2014-12-01)

Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire
by: Scott Anderson, et al.
Published: (2017-10-01)

Carboplatin-pemetrexed in treatment of patients with recurrent/metastatic cancers of the head and neck; superior outcomes in oropharyngeal primaries.
by: Binu eMalhotra, et al.
Published: (2015-01-01)

Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers
by: Paul Reid, et al.
Published: (2020-07-01)

Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma
by: Nikolaos Spathas, et al.
Published: (2018-09-01)

Molecular Tumor Subtypes of HPV-Positive Head and Neck Cancers: Biological Characteristics and Implications for Clinical Outcomes
by: Tingting Qin, et al.
Published: (2021-05-01)

Human papillomavirus genome variants and head and neck cancers: a perspective
by: Jean-Damien Combes, et al.
Published: (2018-04-01)

mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer
by: Sonja Ludwig, et al.
Published: (2020-11-01)

Cannot write session to /tmp/vufind_sessions/sess_trhav56cnqbouv6m2v2qu3t3q5